Fenwick & West represented Day One Biopharmaceuticals in the transaction.Day One Biopharmaceuticals (Nasdaq: DAWN) (“Day One”), a commercial-stage biopharmaceutical company announced its exclusive licensing agreement with…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
